More OncoSil Medical Ltd news
OncoSil Medical LtdASX: OSL

Entitlement Offer Presentation

Mar 16, 2023 at 11:02 PM EDT · Issued by OncoSil Medical Ltd

Filed with ASX · Mar 16, 2023 at 11:02 PM EDT

On 6ix: 6ix.com/news/entitlement-offer-presentation-4

Oncosil Medical Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

OncoSil Medical Ltd on 6ix

In the deck

  • OncoSil Medical — Investor Presentation (March 2023)18 slidesMar 17, 2023

Story so far

  • 2022 AGM CEO PresentationOct 25, 2022
  • Investor PresentationAug 3, 2022
  • 2021 AGM CEO PresentationOct 19, 2021

Earlier from OncoSil Medical

  • Entitlement Offer to raise up to $9.9 millionMar 16, 2023
  • Half-Yearly Report ResultsFeb 28, 2023
  • Half Yearly Report and AccountsFeb 28, 2023
  • Two key treatment centres treat first patients with OncoSilJan 30, 2023
  • OncoSil achieves milestone of 10 patients treated in SpainDec 14, 2022

Later from OncoSil Medical

  • Commitment received for Offer and updated TimetableMar 17, 2023
  • Non-renounceable Rights Issue Offer ProspectusMar 19, 2023
  • Additional Binding Commitment Received for Entitlement OfferApr 21, 2023
  • Further commercial milestones achieved in SpainApr 23, 2023
  • Oral presentation at The Mayo Clinic IMPACT CourseApr 23, 2023
All OncoSil Medical news releases↗

Follow OncoSil Medical into a list and get an email when it puts out news.

Follow OncoSil Medical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer